VRTX R&D Expenses

Vertex Pharmaceuticals · R&D Expenses

VRTX logo

VRTX R&D Expenses

Latest reported$3.96B
VRTX TTM R&D Expenses ($0.00 → $3.96B)
High-resolution chart · PNG

VRTX r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
3,961,300,000
3,945,900,000
3,964,000,000
3,989,000,000
3,832,700,000
8,270,000,000
8,156,200,000
8,509,200,000
8,495,000,000
3,975,500,000
3,852,200,000
3,194,600,000
2,977,900,000
2,681,800,000
2,542,300,000
2,542,500,000
2,391,251,000
3,198,241,000
3,051,114,000
2,823,398,000
2,823,144,000
1,836,982,000
1,829,537,000
1,842,964,000
1,905,415,000
1,863,578,000
1,754,540,000
1,712,410,000
1,486,972,000
1,445,413,000
1,416,476,000
1,285,259,000
1,409,696,000
1,361,615,000
1,324,625,000
1,266,413,000
1,086,836,000
1,068,393,000
1,050,690,000
1,112,667,000
1,083,581,000
1,036,431,000
996,170,000
887,204,000
831,859,000
832,781,000
856,145,000
904,291,000
941,919,000
939,594,000
918,726,000
882,226,000
853,820,000
827,909,000
806,185,000
779,514,000
768,405,000
744,657,000
706,898,000
689,348,000
670,730,000
653,016,000
637,416,000
603,758,000
565,456,000
549,705,000
550,274,000
559,654,000
557,490,000
545,291,000
516,292,000
487,022,000
486,003,000
495,058,000
513,054,000
506,860,000
474,026,000
429,089,000
371,713,000
330,725,000
298,200,000
266,307,000
248,540,000
234,629,000
219,829,000
207,922,000
192,162,000
183,687,000
184,932,000
188,194,000
199,636,000
212,692,000
213,279,000
209,113,000
203,018,000
188,815,000
176,309,000
157,557,000
136,654,000
117,174,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.